The SA Journal Diabetes & Vascular Disease Vol 15 No 1 (July 2018)

43 / 44

for
SUSTAINED
CONTROL
R53,29
SEP excl. VAT
Once daily formulation
Improved compliance 1
Sustained 24 hour glycaemic control 2
60’s
Packed in
25%
less vs.
market
leader
For further product information contact PHARMA DYNAMICS P O Box 30958 Tokai Cape Town 7966 Fax +27 21 701 5898
Email CUSTOMER CARE LINE 0860 PHARMA (742 762) / +27 21 707 7000
DYNA GLICLAZIDE SR 30 mg. Each tablet contains 30 mg gliclazide. S3 A42/21.2/0249. NAM NS2 12/21.2/0110. For full prescribing information, refer to the professional information approved by SAHPRA, 28 July
2017. 1) Crepaldi G and Fioretto P. Gliclazide modified release: Its place in the therapeutic armamentarium. Metabolism 2000;49(10)supplement 2:21-25.2) McGavin JK, et al. Gliclazide modified release. Drugs
2002;62(9):1357-1364. 3) Database of Medicine Prices (12 July 2018). Department of Health website. - Accessed on 12 July 2018.4) IMS MAT UNITS March 2018. DGLJ/539/07/2018.
4 3